Physician profile
Mark Henry Dawson
NPI 1043210271
$2,941.83
in general payments reported to CMS, 2019-2025
39 companies · $320 in 2025
The $320 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $754 · 2020: $182 · 2021: $314 · 2022: $518 · 2023: $421 · 2024: $434 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,174.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $386.56 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $272.00 | 2019-2024 | Prolia, Evenity, Repatha |
| Glaxosmithkline, LLC. | $194.75 | 2019-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $193.87 | 2019-2024 | Verquvo, Vaxneuvance, Gardasil 9 |
| Abbvie INC. | $174.96 | 2020-2025 | Qulipta |
| Corium, LLC | $132.71 | 2022-2025 | Azstarys |
| Novo Nordisk INC | $130.81 | 2019-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $127.46 | 2019-2022 | |
| Tris Pharma INC | $124.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $112.23 | 2019-2024 | Breztri, Tezspire |
| Novartis Pharmaceuticals Corporation | $100.49 | 2019-2023 | |
| Ironshore Pharmaceuticals INC. | $94.34 | 2019-2024 | |
| Exact Sciences Corporation | $75.44 | 2024-2025 | Cologuard Collection Kit |
| Allergan, INC. | $69.22 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $66.66 | 2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dawson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.